CompletedNot Applicable

A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion

1,085 participantsStarted 2014-11-07

Plain-language summary

To evaluate the reasons patients go to more than one prescriber or more than one pharmacy to obtain prescriptions opioids and assess whether the percentage of patients reporting misuse, abuse and/or diversion increases across defined categories of doctor/pharmacy shopping as defined in Study 4A.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. At least two pharmacy claims for any IR or ER/LA opioid analgesic in the most recent 18 months of claims data.
✓. Based on claims for the most recent 18 months of data, meet classification criteria for one of the four a priori defined doctor/pharmacy shopping categories.
✓. Currently active, commercially-insured, survey eligible with medical and pharmacy benefits with a health plan included in the HealthCore Integrated Research Database (HIRD) at the time the sample list is extracted.
✓. At least 18 years of age as of the date of the first IR or ER/LA opioid dispensing in the most recent 18 months of claims data.
✓. A telephone number or address known to HealthCore.

Exclusion criteria

✕. Patients who appear on the HealthCore "Do-not-call" list.
✕. Patients with a known history of abuse
✕. Patients who do not indicate that they have read about all pertinent aspects of the study and agree to participate.
✕. Patients who fail to validate their name and/or date of birth
✕. Patients who are unable to understand the survey questions as designed (e.g., non-English speaking, etc.).
✕. Patients who fail other study-specific screening questions.

What they're measuring

Self-reported reasons that patients go to more than one prescriber or more than one pharmacy, stratified by doctor/pharmacy shopping categories

Timeframe: Day 1, based upon single patient survey completed online or via telephone

Responses suggestive of misuse and/or abuse on the POMAQ.

Timeframe: Day 1, based upon single patient survey completed online or via telephone

Trial details

NCT IDNCT02667158

SponsorMember Companies of the Opioid PMR Consortium

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-12-19

View on ClinicalTrials.gov More Opioid-Related Disorders trials

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. At least two pharmacy claims for any IR or ER/LA opioid analgesic in the most recent 18 months of claims data.
✓. Based on claims for the most recent 18 months of data, meet classification criteria for one of the four a priori defined doctor/pharmacy shopping categories.
✓. Currently active, commercially-insured, survey eligible with medical and pharmacy benefits with a health plan included in the HealthCore Integrated Research Database (HIRD) at the time the sample list is extracted.
✓. At least 18 years of age as of the date of the first IR or ER/LA opioid dispensing in the most recent 18 months of claims data.
✓. A telephone number or address known to HealthCore.

Exclusion criteria

✕. Patients who appear on the HealthCore "Do-not-call" list.
✕. Patients with a known history of abuse
✕. Patients who do not indicate that they have read about all pertinent aspects of the study and agree to participate.
✕. Patients who fail to validate their name and/or date of birth
✕. Patients who are unable to understand the survey questions as designed (e.g., non-English speaking, etc.).
✕. Patients who fail other study-specific screening questions.

What they're measuring

Self-reported reasons that patients go to more than one prescriber or more than one pharmacy, stratified by doctor/pharmacy shopping categories

Timeframe: Day 1, based upon single patient survey completed online or via telephone

Responses suggestive of misuse and/or abuse on the POMAQ.

Timeframe: Day 1, based upon single patient survey completed online or via telephone